Stent Graft of Pseudoaneurysm Rupture After Subtotal Stomach-preserving Pancreaticoduodenectomy.


Journal

Anticancer research
ISSN: 1791-7530
Titre abrégé: Anticancer Res
Pays: Greece
ID NLM: 8102988

Informations de publication

Date de publication:
Aug 2023
Historique:
received: 22 05 2023
revised: 14 06 2023
accepted: 15 06 2023
medline: 31 7 2023
pubmed: 28 7 2023
entrez: 27 7 2023
Statut: ppublish

Résumé

Pseudoaneurysm rupture (PR) after subtotal stomach-preserving pancreaticoduodenectomy (SSPPD) is a potentially fatal complication. This study included 122 patients who underwent SSPPD at the Matsuyama Red Cross Hospital between January 2016 and December 2021. PR occurred in five patients (4.1%) after SSPPD. Preoperative diagnoses were cancers of the pancreatic head, distal bile duct, and gallbladder. All patients had postoperative Grade B or C pancreatic fistulas. PR occurred on postoperative days 8, 13, 20, 45, and 46. Bleeding sites were at the gastroduodenal artery transection, left gastric artery, and right hepatic artery. Four patients underwent peripheral stent graft placement, and one underwent haemostasis by coiling. Stent grafts for the gastroduodenal artery transected stamp were placed in the common hepatic artery, and in the superior mesenteric artery for PR in the right hepatic artery. All patients who underwent stent graft placement were treated with antiplatelet therapy; no complications or stent occlusion were observed in these patients. However, two patients died of cancer recurrence, 4 and 8 months after stent graft placement. The longest survival post stent graft placement was 50 months. Peripheral stent graft placement for the treatment of PR after SSPPD can maintain peripheral blood flow and haemostasis.

Sections du résumé

BACKGROUND/AIM OBJECTIVE
Pseudoaneurysm rupture (PR) after subtotal stomach-preserving pancreaticoduodenectomy (SSPPD) is a potentially fatal complication.
PATIENTS AND METHODS METHODS
This study included 122 patients who underwent SSPPD at the Matsuyama Red Cross Hospital between January 2016 and December 2021.
RESULTS RESULTS
PR occurred in five patients (4.1%) after SSPPD. Preoperative diagnoses were cancers of the pancreatic head, distal bile duct, and gallbladder. All patients had postoperative Grade B or C pancreatic fistulas. PR occurred on postoperative days 8, 13, 20, 45, and 46. Bleeding sites were at the gastroduodenal artery transection, left gastric artery, and right hepatic artery. Four patients underwent peripheral stent graft placement, and one underwent haemostasis by coiling. Stent grafts for the gastroduodenal artery transected stamp were placed in the common hepatic artery, and in the superior mesenteric artery for PR in the right hepatic artery. All patients who underwent stent graft placement were treated with antiplatelet therapy; no complications or stent occlusion were observed in these patients. However, two patients died of cancer recurrence, 4 and 8 months after stent graft placement. The longest survival post stent graft placement was 50 months.
CONCLUSION CONCLUSIONS
Peripheral stent graft placement for the treatment of PR after SSPPD can maintain peripheral blood flow and haemostasis.

Identifiants

pubmed: 37500164
pii: 43/8/3639
doi: 10.21873/anticanres.16544
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3639-3645

Informations de copyright

Copyright © 2023 International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Auteurs

Koichi Kimura (K)

Department of Surgery, Matsuyama Red Cross Hospital, Matsuyama, Japan; cubicseal@gmail.com.

Ryosuke Minagawa (R)

Department of Surgery, Matsuyama Red Cross Hospital, Matsuyama, Japan.

Terutoshi Yamaoka (T)

Department of Vascular Surgery, Matsuyama Red Cross Hospital, Matsuyama, Japan.

Takuma Izumi (T)

Department of Surgery, Matsuyama Red Cross Hospital, Matsuyama, Japan.

Y U Takahashi (YU)

Department of Surgery, Matsuyama Red Cross Hospital, Matsuyama, Japan.

Mitsuru Nakanishi (M)

Department of Surgery, Matsuyama Red Cross Hospital, Matsuyama, Japan.

Takayuki Tokunaga (T)

Department of Surgery, Matsuyama Red Cross Hospital, Matsuyama, Japan.

Daisuke Matsuda (D)

Department of Vascular Surgery, Matsuyama Red Cross Hospital, Matsuyama, Japan.

Kenichi Honma (K)

Department of Vascular Surgery, Matsuyama Red Cross Hospital, Matsuyama, Japan.

Shigeyuki Nagata (S)

Department of Surgery, Matsuyama Red Cross Hospital, Matsuyama, Japan.

Kazuhito Minami (K)

Department of Surgery, Matsuyama Red Cross Hospital, Matsuyama, Japan.

Takashi Nishizaki (T)

Department of Surgery, Matsuyama Red Cross Hospital, Matsuyama, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH